Data fra 366 patienter viser, at ACT ikke påvirkes af samtidig behandling med en GPIIb/ IIIa- inhibitor.
Data from 366 patients indicates that the ACT is unaffected by concomitant treatment with a GPIIb/ IIIa inhibitor.